tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OMER Stock Latest News

Omeros announces publication of narsoplimab survival benefits in TA-TMA
The FlyOmeros announces publication of narsoplimab survival benefits in TA-TMA
2d ago
OMER
Midday Fly By: Big banks beat again, Apple unveils M5
PremiumThe Fly
Midday Fly By: Big banks beat again, Apple unveils M5
3d ago
GS
HI
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
3d ago
MS
BAC
Omeros price target raised to $20 from $9 at H.C. Wainwright
PremiumThe Fly
Omeros price target raised to $20 from $9 at H.C. Wainwright
3d ago
OMER
Unusually active option classes on open October 15th
PremiumThe Fly
Unusually active option classes on open October 15th
3d ago
ALE
QSI
Omeros Signs Major Deal with Novo Nordisk
PremiumCompany AnnouncementsOmeros Signs Major Deal with Novo Nordisk
3d ago
8K
OMER
Omeros up 124% at $9.20 after entering license agreement for zaltenibert
Premium
The Fly
Omeros up 124% at $9.20 after entering license agreement for zaltenibert
3d ago
OMER
Novo Nordisk, Omeros enter asset purchase, license agreement for zaltenibert
Premium
The Fly
Novo Nordisk, Omeros enter asset purchase, license agreement for zaltenibert
3d ago
NVO
OMER
Omeros Corporation Completes Promising Phase 2 Study on OMS906 for PNH
PremiumCompany Announcements
Omeros Corporation Completes Promising Phase 2 Study on OMS906 for PNH
17d ago
OMER
Promising Clinical Data and Unique Mechanism of Narsoplimab Justify Buy Rating
PremiumRatings
Promising Clinical Data and Unique Mechanism of Narsoplimab Justify Buy Rating
2M ago
OMER
Omeros announces publication of narsoplimab survival outcomes in TA-TMA
PremiumThe Fly
Omeros announces publication of narsoplimab survival outcomes in TA-TMA
2M ago
OMER
Omeros Corporation’s Positive Earnings Call Highlights Progress
PremiumCompany Announcements
Omeros Corporation’s Positive Earnings Call Highlights Progress
2M ago
OMER
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
ETH
KGC
Omeros’s Strategic Advancements with Narsoplimab: A Buy Rating Amidst Promising FDA and EMA Reviews
Premium
Ratings
Omeros’s Strategic Advancements with Narsoplimab: A Buy Rating Amidst Promising FDA and EMA Reviews
2M ago
OMER
Omeros Corporation Reports Q2 2025 Financial Results
Premium
Company Announcements
Omeros Corporation Reports Q2 2025 Financial Results
2M ago
OMER
Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
PremiumThe Fly
Closing Bell Movers: UnitedHealth jumps 10% as Berkshire, Appaloosa buy weakness
2M ago
NUE
UNH
Omeros reports Q2 EPS (44c), consensus (55c)
PremiumThe Fly
Omeros reports Q2 EPS (44c), consensus (55c)
2M ago
OMER
H.C. Wainwright says study could be tailwind to uptake of Omeros’ narsoplimab
PremiumThe Fly
H.C. Wainwright says study could be tailwind to uptake of Omeros’ narsoplimab
3M ago
OMER
Potential Market Surge for Omeros Driven by Narsoplimab’s Edge Over Eculizumab
PremiumRatings
Potential Market Surge for Omeros Driven by Narsoplimab’s Edge Over Eculizumab
3M ago
OMER
Omeros Enters Securities Purchase Agreement with Polar
PremiumCompany AnnouncementsOmeros Enters Securities Purchase Agreement with Polar
3M ago
8K
OMER
Omeros to sell 5.366M shares at $4.10 in registered direct offering
Premium
The Fly
Omeros to sell 5.366M shares at $4.10 in registered direct offering
3M ago
OMER
Omeros submission adds another 2026 catalyst, says H.C. Wainwright
Premium
The Fly
Omeros submission adds another 2026 catalyst, says H.C. Wainwright
4M ago
OMER

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >